hyperphosphatemia in stage 5 ckd · 2018. 8. 31. · 7-dehydrocholesterol cholecalciferol (d 3) ......
TRANSCRIPT
-
Hyperphosphatemia in Stage 5 CKD
Consequences And
Management
-
Bone and Mineral Metabolism in CKD ↓ Renal Function
Phosphate Retention ↓ 1,25 D Production
↑ PTH ↓ Ca+ Decreased VDR expression
Altered Parathyroid Gland Function ➙ Hyperplasia ➙ SHPT
CONSEQUENCES Renal Osteodystrophy Fractures Calcification CV Disease
MORBIDITY & MORTALITY
↑ PO4
Hyperphosphatemia
-
What are the different sources of vitamin D?
Precursor or pro-hormones found in: Skin - 7 dehydrocholesterol D3 Diet
- Animal Source: Cholecalciferol=D3 - Plant Source: Ergocalciferol = D2
-
Metabolic Pathways of Vitamin D 2 and D 3
7-dehydrocholesterol
Cholecalciferol (D3)
25-hydroxycholecalciferol
1,25-dihydroxyergocalciferol 1,25-dihydroxycholecalciferol
Dietary Sources
Liver
Kidney
(25-hydroxylase)
(1 -hydroxylase)
1,25(OH)2D2 1,25(OH)2D3
Ergosterol
Ergocalciferol (D2)
25-hydroxyergocalciferol
UV Light
-
What are the normal levels of vitamin D? How are they affected?
Average production of active vitamin D hormone by healthy kidneys = 1-2 mg/day
Average serum level of active vitamin D hormone = 20 -70 pg/ml (pg=1 trillionth of a gram)
Seasonal and developmental variation in serum levels
Age Lifestyle Geographical location
seasonal Race Culture
-
Severe Vitamin D Deficiency
Vitamin D Status1
1. National Kidney Foundation (NKF). K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1-S201.
5-15 ng/mL
30 ng/mL
Note: A patient’s vitamin D status is typically assessed by measuring serum 25(OH)D1
25(OH)D Insufficiency and Deficiency
-
X
Osteoclast
Ca2+
Bone
Blood Ca2+ (& PO4)
Kidney
Ca2+
PO4
D hormone
Parathyroid Gland
Intestine
-
1 -hydroxylase
1,25(OH)2D 25(OH)D
1 -hydroxylase
1,25(OH)2D 25(OH)D
Normal
CKD Decreasing Renal Mass
Elevated phosphorus and uremia suppress the activity of 1 -hydroxylase in the kidney
↑FGF 23
Vitamin D Deficiency in CKD
-
Balance between Protein Synthesis and Catabolism
A shift in balance between protein synthesis and breakdown toward catabolism can cause an increase in serum phosphorus1:
Infection Trauma Starvation
1NKF. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in CKD.Am J Kidney Dis. 2003; 42(suppl 3)
-
Hidden Sources of Phosphorus
173 mg/12 oz
53 mg/12 oz
53-140 mg/12 oz 134 mg/12 oz 93 mg/12 oz
49 mg/12 oz
37 mg/12 oz
115 mg (from mix)
98-150 mg/biscuit
89 mg/10 inch Flour tortilla
66 mg/12 oz with lemon or raspberry
http://www.supereggplant.com/archives/biscuits.JPG
-
PhosLo GENERIC NAME(S): CALCIUM ACETATE
Renvela Sevelamer carbonate
-
Serum Calcium
Serum Calcium
Bound To Protein
40%
Complexed10%
Free (Ionized)50%
Friedman PA, Tenenhouse HS. Renal Handling of Calcium and Phosphorus. Disorders of Bone and Mineral Metabolism. Lippincott Williams and Wilkins. Philadelphia, PA, 2nd Edition, 2002
-
Corrected Calcium Serum Calcium should be “corrected” or “adjusted” in the presence of hypoalbuminemia A formula often used for correcting/adjusting calcium is: a) 4.0 minus patient’s serum albumin = X b) X times 0.8 = Y c) Patient’s serum calcium plus Y = corrected serum
calcium
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J
Kidney Dis 2003; 42 Suppl 3: 80.
-
Positive calcium balance may not be reflected in serum calcium
Homeostatic control works to maintain normal serum calcium
-
KT/V AND BUN
• KT/V tells us whether a patient is receiving adequate dialysis.
• Normal is 1.2 or greater.
• BUN (blood urea nitrogen) 60-80 is normal in dialysis patients. We seldom look at this because the kt/v is what is important..
• Patients rarely receive too much protein
-
Be in the Cool Crowd: Meet your Goals!
Your Lab Goals: Albumin: 3.5 or higher Hemoglobin: 10-12 Calcium: 8.4-10.2 Phosphorus: 3.0-5.5 PTH 150-600 Potassium: 3.5-5.5 Kt/V: 1.2 or higher Weight Gain Between Treatments: 3 kg or less Copyright DaVita, Inc. 2011